Exelixis Inc (EXEL)
23.28
+0.42
(+1.81%)
USD |
NASDAQ |
Apr 23, 16:00
23.28
0.00 (0.00%)
After-Hours: 17:36
Exelixis Price to Book Value: 3.118 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 3.063 |
| April 19, 2024 | 3.016 |
| April 18, 2024 | 3.012 |
| April 17, 2024 | 3.063 |
| April 16, 2024 | 3.056 |
| April 15, 2024 | 3.040 |
| April 12, 2024 | 3.055 |
| April 11, 2024 | 3.033 |
| April 10, 2024 | 3.171 |
| April 09, 2024 | 3.177 |
| April 08, 2024 | 3.127 |
| April 05, 2024 | 3.099 |
| April 04, 2024 | 3.146 |
| April 03, 2024 | 3.173 |
| April 02, 2024 | 3.126 |
| April 01, 2024 | 3.171 |
| March 28, 2024 | 3.178 |
| March 27, 2024 | 3.195 |
| March 26, 2024 | 3.162 |
| March 25, 2024 | 3.174 |
| March 22, 2024 | 3.185 |
| March 21, 2024 | 3.204 |
| March 20, 2024 | 3.175 |
| March 19, 2024 | 3.143 |
| March 18, 2024 | 3.103 |
| Date | Value |
|---|---|
| March 15, 2024 | 3.078 |
| March 14, 2024 | 3.028 |
| March 13, 2024 | 3.090 |
| March 12, 2024 | 3.039 |
| March 11, 2024 | 3.008 |
| March 08, 2024 | 2.974 |
| March 07, 2024 | 2.958 |
| March 06, 2024 | 2.997 |
| March 05, 2024 | 2.981 |
| March 04, 2024 | 3.02 |
| March 01, 2024 | 2.978 |
| February 29, 2024 | 2.933 |
| February 28, 2024 | 2.934 |
| February 27, 2024 | 2.908 |
| February 26, 2024 | 2.941 |
| February 23, 2024 | 2.883 |
| February 22, 2024 | 2.774 |
| February 21, 2024 | 2.775 |
| February 20, 2024 | 2.763 |
| February 16, 2024 | 2.743 |
| February 15, 2024 | 2.758 |
| February 14, 2024 | 2.731 |
| February 13, 2024 | 2.709 |
| February 12, 2024 | 2.731 |
| February 09, 2024 | 2.708 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.937
Minimum
Oct 10 2022
4.811
Maximum
May 11 2020
3.159
Average
3.083
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 3.834 |
| Bristol-Myers Squibb Co | 3.367 |
| Johnson & Johnson | 5.241 |
| Bio-Techne Corp | 5.096 |
| Legend Biotech Corp | 6.912 |
Price to Book Value Related Metrics
| PE Ratio | 36.20 |
| PS Ratio | 4.090 |
| PEG Ratio | 2.816 |
| Price to Free Cash Flow | 43.94 |
| Price | 23.28 |
| Earnings Yield | 2.76% |
| Market Cap | 7.060B |
| PEGY Ratio | 2.816 |
| Operating PE Ratio | 43.80 |
| Normalized PE Ratio | 36.20 |